Clinical Trials Directory

Trials / Completed

CompletedNCT00469807

Ghrelin Levels in Early IVF Pregnancies

Maternal Serum Ghrelin Levels in Early IVF Pregnancies: Lack of Prognostic Value for Gestational Outcome and Altered Post-Prandial Responses

Status
Completed
Phase
Study type
Observational
Enrollment
Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

In this study, we have assessed the potential prognostic value for gestational outcome of maternal ghrelin levels at very early stages of IVF pregnancies. In addition, ghrelin responses to meal intake were explored at early gestation.

Detailed description

Ghrelin is a pleiotropic hormone recently involved in the control of growth and metabolism, whose circulating levels fluctuate in relation to food intake and body mass index. Ghrelin has been detected in the decidualized endometrium, as well as in human and rat placenta, with a distinctive temporal pattern of expression along pregnancy. Comparison(s): A total of 106 patients undergoing IVF procedures were prospectively recruited. On d-16 and 23 after oocyte retrieval, the patients were subjected to blood sampling after overnight fasting, for determination of serum ghrelin, hCG and progesterone levels. In addition, ghrelin levels were assayed in these groups, 2-h after ingestion of a fixed-calorie meal.

Conditions

Timeline

Start date
2004-06-01
Completion
2007-05-01
First posted
2007-05-07
Last updated
2017-04-28

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT00469807. Inclusion in this directory is not an endorsement.

Ghrelin Levels in Early IVF Pregnancies (NCT00469807) · Clinical Trials Directory